Class II
Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6951-61
Subpotent Drug
- Recall number
- D-0702-2026
- Report date
- July 29, 2026
- Classification
- Class II
- Status in dataset
- Ongoing
- Recalling firm
- Major Pharmaceuticals
- Generic names
- LEVOTHYROXINE SODIUM
- Brand names
- LEVOTHYROXINE SODIUM
- Product NDCs
- 0904-6949, 0904-6950, 0904-6951, 0904-6952, 0904-6953, 0904-6954, 0904-6955, 0904-6956, 0904-6957
Code and lot information
Lot# N02172, exp 07/2026; N02296, N02288, Exp. Date 12/2026
Distribution
Nationwide in the USA.
Do not stop or change a prescribed medication based only on this page.Contact your pharmacist or prescriber and compare the exact product, manufacturer, NDC, and lot information.
Source and limitations
This page reflects a public openFDA Drug Enforcement record. The dataset was last checked on September 23, 2026. openFDA states that enforcement data should not be used alone to issue public alerts or track the full lifecycle of a recall.
Review the official FDA Drug Recalls page and the underlying openFDA query.